AstraZeneca (AZN)
NASDAQ: AZN
· Real-Time Price · USD
79.23
0.76 (0.97%)
At close: Aug 15, 2025, 2:30 PM
AstraZeneca Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 9.54B | 8.81B | 8.69B | 7.92B | 7.75B | 7.44B | 6.9B | 6.78B | 6.05B | 4.21B | 2.5B | 1.09B | -1.84B | -1.32B | -265M | 1.38B | 4.24B | 4.43B |
Depreciation & Amortization | 5.2B | 5.09B | 5.07B | 5.22B | 4.69B | 4.69B | 4.93B | 5.54B | 5.59B | 5.67B | 5.48B | 6.19B | 7.65B | 7.04B | 6.53B | 4.88B | 2.9B | 2.85B |
Stock-Based Compensation | n/a | n/a | n/a | 579M | 579M | 579M | 579M | 619M | 619M | 619M | 619M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -1.08B | -864M | -893M | -693M | 163M | -697M | n/a | -2.14B | -1.97B | -397M | 1.17B | 1.4B | 1.53B | 594M | n/a | 2.32B | 1.64B | 1.66B |
Other Non-Cash Items | -272M | 51M | -1B | -1.42B | -1.83B | -2.03B | -1.79B | -2.41B | -2.08B | -2.37B | -1.93B | -462M | -342M | 329M | -918M | -880M | -963M | -987M |
Deferred Income Tax | n/a | n/a | n/a | -579M | -579M | -579M | -579M | -619M | -619M | -619M | -619M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.08B | -864M | -893M | -393M | 463M | -397M | 300M | 449M | 619M | 2.19B | 3.76B | 2.01B | 2.15B | 1.21B | 616M | 958M | 277M | 295M |
Operating Cash Flow | 13.39B | 13.09B | 11.86B | 11.33B | 11.06B | 9.7B | 10.35B | 10.36B | 10.18B | 9.71B | 9.81B | 8.83B | 7.62B | 7.26B | 5.96B | 6.34B | 6.45B | 6.59B |
Capital Expenditures | -4.67B | -3.41B | -4.59B | -4.58B | -4.1B | -3.91B | -3.78B | -3.39B | -3.62B | -3.68B | -2.57B | -2.73B | -2.28B | -2.09B | -2.2B | -2.03B | -2.08B | -2.7B |
Cash Acquisitions | -1.18B | -3.21B | -3.79B | -3.81B | -3.81B | -1.69B | -1.18B | -1.07B | -1.14B | -1.25B | -1.06B | -1.09B | -10.38B | -10.22B | -9.43B | -9.37B | -57M | -105M |
Purchase of Investments | -217M | 2M | 2M | -13M | -79M | -136M | -136M | 69M | -157M | -155M | -159M | -343M | -202M | -188M | 65M | 244M | 901M | 907M |
Sales Maturities Of Investments | 129M | 99M | 108M | 237M | 122M | 119M | 129M | 32M | 98M | 8M | 42M | 27M | 14M | 130M | 105M | 595M | 849M | 1.87B |
Other Investing Acitivies | -2.57B | -1.77B | -1.19B | -936M | -8M | 392M | 900M | 1.12B | 1.06B | 1.03B | 789M | 517M | 502M | 596M | 405M | 558M | 259M | 286M |
Investing Cash Flow | -6.06B | -6.82B | -7.98B | -7.88B | -7.58B | -5.23B | -4.06B | -3.24B | -3.76B | -4.04B | -2.96B | -3.62B | -12.35B | -11.78B | -11.06B | -10.01B | -123M | 261M |
Debt Repayment | -1.3B | -3.07B | 1.81B | 2.18B | 3.39B | 3.09B | -965M | -801M | 466M | 667M | -1.33B | -2.11B | -573M | -3M | 21M | -785M | 92M | 1.94B |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -4.94B | -4.94B | -4.63B | -4.63B | -4.46B | -4.47B | -4.48B | -4.48B | -4.46B | -4.44B | -4.36B | -4.36B | -4.36B | -4.36B | -3.86B | -3.86B | -3.64B | -3.64B |
Other Financial Acitivies | -224M | -195M | -1.13B | -1.12B | -1.18B | -1.16B | -1.15B | -1.38B | -1.37B | -1.37B | -1.16B | -1.07B | -1.04B | 6.98B | 7.46B | 7.11B | 7.12B | -895M |
Financial Cash Flow | -6.99B | -8.73B | -4B | -3.62B | -2.21B | -2.51B | -6.57B | -6.63B | -5.34B | -5.11B | -6.82B | -7.52B | -5.94B | 2.64B | 3.65B | 2.49B | 3.59B | -2.57B |
Net Cash Flow | 355M | -2.48B | -208M | -184M | 1.21B | 1.86B | -346M | 433M | 991M | 475M | -55M | -2.39B | -10.72B | -1.88B | -1.51B | -1.22B | 9.89B | 4.26B |
Free Cash Flow | 8.72B | 9.68B | 7.28B | 6.76B | 6.97B | 5.79B | 6.57B | 6.98B | 6.56B | 6.03B | 7.24B | 6.09B | 5.33B | 5.17B | 3.76B | 4.31B | 4.37B | 3.9B |